Daily Chart

Popular Trending Tickers


Ticker Sitemap
Will CKGT go up?

Send a Tweet

$CKGT
#China Kangtai Cactus Bio-Tech
CKGT
China Kangtai Cactus Bio-Tech
Look for:

Warning: fopen(/home/stweet/public_html/components/com_stocksonline/cache/tweetCache/cache_CKGT_html) [function.fopen]: failed to open stream: Permission denied in /home/stweet/public_html/components/com_stocksonline/library/class.cache.php on line 66

China Kangtai Cactus Bio-Tech Inc. - CKGT Insiders

No Insiders

We have no insiders for China Kangtai Cactus Bio-Tech right now.

Know someone who is an insider on China Kangtai Cactus Bio-Tech Inc.?
Let us know.

China Kangtai Cactus Bio-Tech Inc. - CKGT/CKGT.OB information

China Kangtai Cactus Bio-Tech, Inc., through its subsidiaries, engages in the production, research and development, sale, and marketing of products derived from cacti in the People’s Republic of China. Its product lines include cactus nutriceuticals, cactus nutritional food and drinks, and cactus raw and intermediate materials. The company’s nutriceutical products containing cactus extracts include Cactus Protein Nutrient, Cactus Calcium Peptide Soft Capsule, and Cactus Shuxin Capsule. It also offers health foods comprising cactus liquor and juice; and cactus drinks, which include cactus beer, cactus fruit wine, cactus beverage, cactus palm juices, and cactus fruit drink, as well as cactus p......
www.xrz.cn
132 Employees

CHINA KANGTAI CACTUS BIO-TEC (CKGT:OTC BB)

LAST $1.22 USD
CHANGE TODAY 0.00 0.00%
VOLUME 11.8K
As of 8:10 PM 07/30/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of CHINA KANGTAI CACTUS BIO-TEC (CKGT)

OPEN
$1.27
PREVIOUS CLOSE
$1.22
DAY HIGH
$1.27
DAY LOW
$1.22
52 WEEK HIGH
01/11/10 - $3.00
52 WEEK LOW
07/31/09 - $0.75
MARKET CAP
25.6M
AVERAGE VOLUME 10 D
27.7K
EPS TTM
$0.09
SHARES OUTSTANDING
21.0M
CKGT Does Not Pay Dividends
P/E TTM
13.6x
K = Thousands  M = Millions  B = Billions
[addPosition2]

Key developments for CHINA KANGTAI CACTUS BIO-TEC (CKGT)

China Kangtai Cactus Bio-Tech Inc. expected to report Fiscal Year 2010 results on April 15, 2011. This event was calculated by Capital IQ (Created on June 27, 2010).

China Kangtai Cactus Bio-Tech Inc. expected to report Fiscal Year 2010 results on April 15, 2011. This event was calculated by Capital IQ (Created on June 27, 2010).

China Kangtai Cactus Bio-Tech Inc. expected to report Q2 2010 results on August 13, 2010. This event was calculated by Capital IQ (Created on June 27, 2010).

China Kangtai Cactus Bio-Tech Inc. expected to report Q2 2010 results on August 13, 2010. This event was calculated by Capital IQ (Created on June 27, 2010).

China Kangtai Cactus Bio-Tech Inc. Announces Financial Results for the First Quarter Ended March 31, 2010

China Kangtai Cactus Bio-Tech Inc. announced financial results for the first quarter ended March 31, 2010. For the quarter, the company reported revenue increased 66% to $5.5 million from $3.3 million in the first quarter of 2009. Adjusted net income was up 20.5% to $836,723 or $0.04 per share. GAAP net income was $2.4 million versus $956,673 for the same period a year ago. Income from operations increased 34% to $1.2 million from $880,530 in 2009. Net cash provided by operating activities was $4.5 million, an improvement from $856,907 a year earlier.

CKGT Competitors

Company Last Change
No competitor information is available for CKGT.
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation CKGT Industry Range
Price/Earnings 13.1x
Price/Sales 0.9x
Price/Book 0.8x
Price/Cash Flow 12.0x
TEV/Sales 0.8x

CKGT

 | 

CKGT transactions

Type
Date
Target
Private Placement
July 9, 2010
--

China Kangtai Cactus Bio-Tech Inc. - CKGT/CKGT.OB news

China Kangtai Cactus Announces $1M Equity Infusion from Kodiak Capital Group

Keywords: China Kangtai Cactus Announces $1M Equity Infusion from Kodiak Capital Group, ckgt.ob
Quote:
Read article

CHINA KANGTAI CACTUS BIO-TECH, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement

Quote: Item 1.02Entry into a Material Definitive Agreement. On June 28, 2010, China Kangtai Cactus Bio-Tech, Inc. (the "Company") through its wholly-owned subsidiary, Harbin Hainan Kangda Cacti Hygienical Foods Co., Ltd. entered into an Asset Purchase Agreement (the "Agreement") with Dadi Tobacco Trade Center (the "Seller") of Raoping County in Guangdong Province of China. The Company has agreed to purchase from Seller certain real property and all improvements thereon, a...
Read article

China Kangtai Cactus Biotech Announces Acquisition of Tobacco Manufacturer

Keywords: China Kangtai Cactus Biotech Announces Acquisition of Tobacco Manufacturer, ckgt.ob
Quote:
Read article

CHINA KANGTAI CACTUS BIO-TECH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stateme

Quote: Item 1.02Entry into a Material Definitive Agreement. On June 28, 2010, China Kangtai Cactus Bio-Tech, Inc. (the "Company") through its wholly-owned subsidiary, Harbin Hainan Kangda Cacti Hygienical Foods Co., Ltd. entered into an Asset Purchase Agreement (the "Agreement") with Dadi Tobacco Trade Center (the "Seller") of Raoping County in Guangdong Province of China. The Company has agreed to purchase from Seller certain real property and all improvements thereon, a...
Read article

Afraid of Chinese OTC Stocks? Two You Might Like

Quote: Take a company like China Kangtai Cactus Bio-Tech (CKGT.OB). The company is a leading grower, developer, producer and marketer of cactus-derived products. Cactus had been used since ancient times as both a food and as medicine for its health benefits. The fact that no net income guidance was provided and that no color on margins was provided in the press release will keep investors in limbo regarding EPS. Geo Investing's low end EPS estimate from......
Read article

China Kangtai Cactus Biotech Q1 Revenue Up 66% to $5.5M; Adjusted Net Income up 20.5%; Reports Strong Cash Generation From Operations

Keywords: China Kangtai Cactus Biotech Q1 Revenue Up 66% to $5.5M; Adjusted Net Income up 20.5%; Reports Strong Cash Generation From Operations, ckgt.ob, earnings
Quote:
Read article

CHINA KANGTAI CACTUS BIO-TECH, INC. Files SEC form 10-Q, Quarterly Report

Quote:
Read article

China Kangtai Cactus Biotech Terminates Funding Agreement

Keywords: China Kangtai Cactus Biotech Terminates Funding Agreement, ckgt.ob
Quote:
Read article

CHINA KANGTAI CACTUS BIO-TECH, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Sta

Quote: Item 1.02Termination of a Material Definitive Agreement. On April 30, 2010, China Kangtai Cactus bio-Tech, Inc. (the "Company") entered into a termination agreement (the "Termination Agreement") with Seaside 88, LP ("Seaside") pursuant to which the parties agreed to mutually terminate the Common Stock Purchase Agreement, dated November 5, 2009, between the Company and Seaside 88, LP (the "Purchase Agreement") with no further obligations. The parties agree...
Read article

China Kangtai Cactus Biotech 2009 Revenue Up 31% to $26.5M; Reports Strong Cash Generation From Operations

Quote:
Read article

CHINA KANGTAI CACTUS BIO-TECH, INC. Files SEC form 10-K, Annual Report

Quote:
Read article

China Kangtai Cactus Biotech Signs Sales Agreement with Chinese Retailer To Market Cactus-Based Health Products Across China

Quote:
Read article

China Kangtai Cactus Biotech Announces Preliminary FY 2009 Results and Forecasts FY 2010 Guidance

Quote:
Read article

China Kangtai Cactus Biotech Announces Preliminary FY 2009 Results and Forecasts FY 2010 Guidance

Quote:
Read article

China Kangtai Cactus Biotech Says Q4 New Product Sales Exceeded Expectations

Quote:
Read article

China Kangtai Cactus Biotech Adopts EITF 07-05, Expects to File Amended 10-Q, 10-K

Quote:
Read article

China Kangtai Cactus Biotech Awarded $2.1 Million Contract for Patented Cactus-based Low and Zero Nicotine Cigarettes

Quote:
Read article

China Kangtai Cactus Biotech Receives $5.94 Million for Transfer of Property and Equipment to Local Government; Company Says No Impact on Operations

Quote:
Read article

China Kangtai Cactus Biotech Receives $5.94 Million for Transfer of Property and Equipment to Local Government; Company Says No Impact on Operations

Quote:
Read article

China Kangtai Cactus Biotech Awarded $2.1 Million Contract for Patented Cactus-based Low and Zero Nicotine Cigarettes

Quote:
Read article
Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.